Fewer Americans age 60 to 74 should receive the shots, the agency concluded, citing reduced risks and a possible neurological side effect.
[ad_2]
Source link
C.D.C. Scales Back Recommendations for R.S.V. Vaccine
You May Also Like
More From Author
Using an adaptive modeling framework to identify avian influenza spillover risk at the wild-domestic interface
